| Bioactivity | WJ-39 is an orally active aldose reductase (AR) inhibitor. WJ-39 improves tubular damage in diabetic nephropathy rats by activating PINK1/Parkin signaling, promoting mitophagy, and attenuating apoptosis[1]. |
| CAS | 3009908-95-3 |
| Formula | C19H14Cl2KNO4 |
| Molar Mass | 430.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yang L, et al. An aldose reductase inhibitor, WJ-39, ameliorates renal tubular injury in diabetic nephropathy by activating PINK1/Parkin signaling. Eur J Pharmacol. 2024 Mar 15;967:176376. |
WJ-39
CAS: 3009908-95-3 F: C19H14Cl2KNO4 W: 430.32
WJ-39 is an orally active aldose reductase (AR) inhibitor. WJ-39 improves tubular damage in diabetic nephropathy rats by
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.